Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-02-27

Clinical Trial Update: Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents [Phase 3]

View source ↗

Summary

The Phase 3 clinical evaluation of the T.R.U.E. TEST Panel 3.2 in children and adolescents for contact dermatitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Allerderm | Conditions: Contact Dermatitis | Phase 3 | Status: WITHDRAWN